A pairing appears on this page only when a trial gave both ingredients together and measured the result. Monoglyceride has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Long-chain omega-3 fatty acids delivered already esterified in monoglyceride form skip the pancreatic lipase step that ethyl esters and triglycerides require. In the human pharmacokinetic work by Chevalier and colleagues the monoglyceride form produced higher plasma appearance than the ethyl ester comparator. Plasma appearance is an absorption marker, not a clinical outcome, so this says the fatty acid gets in more readily and says nothing yet about what that changes downstream. The practical relevance is greatest for people with low lipase or low bile output.
Curcuminoids are poorly water soluble and their absorption depends heavily on the vehicle they arrive in. Aguilera and colleagues compared curcuminoid formulations carried in an omega-3 monoglyceride matrix against other formulations in a randomised human design and measured plasma curcuminoid appearance. A carrier that raises plasma levels is doing exactly the job a carrier is meant to do. Whether the higher plasma exposure translates into any different effect was not what the study measured.
Bile salts emulsify dietary fat and form the mixed micelles that carry digestion products to the brush border. Monoglycerides are themselves amphipathic and participate in micelle formation rather than merely riding in it. Because a pre-formed monoglyceride has already cleared the lipolysis step, its uptake leans less on bile than an intact triglyceride does. For someone with reduced bile flow, that difference is the whole point of the form.
Pancreatic lipase cleaves the outer two positions of a dietary triglyceride and leaves a 2-monoglyceride plus two free fatty acids. That 2-monoglyceride is the physiological absorption species, taken up at the enterocyte and re-esterified inside the cell. A supplemental monoglyceride is therefore not a novel molecule but the normal endpoint of fat digestion supplied directly. Adding lipase to a monoglyceride does little for the monoglyceride itself, though it still matters for any intact fat eaten alongside.
Vitamin D3 needs a lipid phase and micellar solubilisation to cross the intestinal barrier in useful amounts. Monoglycerides are among the natural components of intestinal mixed micelles, so a monoglyceride-based carrier provides the physical environment the vitamin needs. The same logic applies to the other fat-soluble vitamins. This is formulation physics rather than a metabolic interaction between two actives.
Coenzyme Q10 is one of the least water-soluble compounds in common supplement use, and its absorption is famously vehicle-dependent. A monoglyceride carrier gives it a lipid phase and helps it into mixed micelles. Formulators use this class of emulsifier for exactly that reason. The magnitude of the gain varies by product and is not a fixed number.
Astaxanthin is a xanthophyll carotenoid and, like the whole carotenoid class, is absorbed only when it partitions into a lipid phase and then into micelles. Monoglycerides supply that phase in an emulsified format that does not need much digestive work. Carotenoid uptake without co-ingested fat is markedly poorer, which is the reason such products are almost always oil based.
Lutein absorption tracks the amount and type of fat eaten with it. A monoglyceride-containing emulsion raises the fraction that reaches the micellar phase compared with a dry powder taken on an empty stomach. This is an absorption statement, measured as plasma or macular pigment response depending on the study design, and it does not by itself claim any functional endpoint.
Medium-chain monoglycerides such as monocaprylin and monolaurin are the monoacylglycerol counterparts of the fatty acids that make up MCT oil. Both deliver medium-chain fatty acids, but the monoglyceride form arrives partly pre-digested and retains surfactant activity that plain MCT triglyceride does not have. In animal feeding work the two are often used for different purposes, MCT for energy and the monoglycerides for gut effects. Read the overlap as chemical family rather than interchangeability.
Monolaurin and related medium-chain monoglycerides disrupt bacterial membranes, which is precisely why they are used as feed additives for gut microbial control. That activity is not selective enough to guarantee it spares a supplemental probiotic strain taken at the same time. In the broiler and piglet literature monoglyceride blends measurably shift cecal microbial community composition. Separating the doses by a few hours is a reasonable formulation precaution rather than a demonstrated requirement.
Monoglyceride blends and butyrate sources are commonly co-formulated in animal feed additives aimed at intestinal integrity, and several of the piglet and broiler studies use blends containing both classes. Because the products are tested as blends, the contribution of each component is not separable from the published results. There is no human trial of this pairing. The relationship is documented at the formulation level, not the mechanism level.
Mezzina and colleagues examined zinc oxide alongside a monoglyceride blend in weanling pigs and reported effects on intestinal immune and microbiota measures. Pharmacological zinc oxide in weaning pigs is a veterinary practice with no human parallel at those doses. The pairing is therefore informative about mechanism direction and not transferable to a human supplement stack.
Lecithin and monoglycerides are the two workhorse food-grade emulsifiers, and they are routinely combined because they stabilise different parts of an emulsion. Lecithin is a phospholipid with a bulky polar head, the monoglyceride a smaller single-chain surfactant, and together they pack a more stable interfacial film than either alone. This is process chemistry with no metabolic claim attached.
Tocopherols need a lipid phase for absorption in the same way the other fat-soluble vitamins do, so a monoglyceride carrier serves them well. Separately, vitamin E is added to unsaturated monoglyceride and omega-3 preparations to slow oxidation of the fatty acid chains during shelf life. Both roles are real and they are different roles, one physiological and one about product stability.
Nothing specific on file for Monoglyceride. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.These are the studies our verdict leans on, chosen from the 11 we read for Monoglyceride. The full linked list is below.
2 sources behind our Monoglyceride verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.